Shilpa Gupta

Results from BLASST-1 (Bladder Cancer Signal Seeking Trial) of nivolumab, gemcitabine, and cisplatin in muscle invasive bladder cancer (MIBC) undergoing cystectomy.

Shilpa Gupta, Guru Sonpavde, Christopher Weight et al. · Journal of Clinical Oncology · 2020 · 134 citations

Radical Cystectomy, Surgical Oncology, Urology +12

Significance of Incidental Desmoids Identified During Surgery for Familial Adenomatous Polyposis

John E. Hartley, James M. Church, Shilpa Gupta et al. · Diseases of the Colon & Rectum · 2004 · 97 citations

EV-103: Initial results of enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma

Christopher Hoimes, Jonathan E. Rosenberg, S. Srinivas et al. · Annals of Oncology · 2019 · 52 citations · Full text

Urology, Metastatic Urothelial Carcinoma, Initial Results +7

A phase II randomized, double-blind study of sipuleucel-T followed by IDO pathway inhibitor, indoximod, or placebo in the treatment of patients with metastatic castration resistant prostate cancer (mCRPC).

Gautam Jha, Shilpa Gupta, Scott T. Tagawa et al. · Journal of Clinical Oncology · 2017 · 39 citations

Indoximod Arm, Immunology, Immune Regulation +25

Randomized double-blind phase II study of maintenance pembrolizumab versus placebo after first-line chemotherapy in patients (pts) with metastatic urothelial cancer (mUC): HCRN GU14-182.

Matt D. Galsky, Sumanta K. Pal, Amir Mortazavi et al. · Journal of Clinical Oncology · 2019 · 25 citations

Metastatic Urothelial Cancer, Urology, Genitourinary Cancer +13